Advertisement

CDC: 20.4 Percent of U.S. Adults Had Chronic Pain in 2019

0

Chronic pain and high-impact chronic pain higher among women, adults ages 65 years and older

Major Neurological Disorders on the Rise in the United States

0

Burden increasing largely due to aging of the U.S. population

Eli Lilly Antibody Drug Could Prevent COVID Hospitalizations: Study

Cognitive Disorders More Common in People Admitted for COVID-19

0

Genetic variations may put some individuals at higher risk for severe infection

Online Program, Population Health Management Combo Aids Weight Loss

0

Combo yielded greatest weight loss for obese, overweight patients over 12 months

Dermatologic Manifestations of COVID-19 May Persist

Dermatologic Manifestations of COVID-19 May Persist

0

Papulosquamous eruptions, pernio/chilblains last ≥60 days in some patients

Incidence of Cerebrovascular Disease Quantified in COVID-19

0

1.4 percent of patients with COVID-19 have acute cerebrovascular disease, most often acute ischemic stroke

Testing of the Eli Lilly antibody drug for hospitalized COVID-19 patients has been halted because the treatment does not help them recover from their infection.

Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness

0
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients
The U.S. Centers for Disease Control and Prevention has issued an alert about a multistate outbreak of Listeria monocytogenes infections.

CDC Warns of Multistate Listeria Outbreak

0
All 10 infected people were hospitalized; one death reported in Florida
The U.S. Preventive Services Task Force (USPSTF) concludes that there is a substantial net benefit for screening adults age 50 to 75 years for colorectal cancer and moderate net benefit for adults ages 45 to 49 years. These findings form the basis of a draft recommendation statement published online Oct. 27 by the USPSTF.

USPSTF Issues Draft Recommendation for CRC Screening

0
Benefit substantial for adults aged 50 to 75 years; benefit moderate for adults aged 45 to 49 years
Adults with psychosocial and health-related risk factors have an increased risk for experiencing moderate or severe depressive symptoms during the COVID-19 pandemic

Risk Factors ID’d for More Severe Depressive Symptoms During COVID-19 Pandemic

0
Physical, psychological abuse, preexisting health conditions, low social support, low SEP linked to risk